Monocacy Therapeutics Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Angel

  • Latest Deal Amount
  • $25K

  • Investors
  • 2

Monocacy Therapeutics General Information

Description

Developer of an AI-guided immunotherapy platform designed to restore immune function and develop next-generation therapies. The company's platform provides AI-powered immunology research and therapy development capabilities, enabling clients to access immune-based therapeutic approaches for improved immune function and health outcomes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 321 Ballenger Center Drive
  • Suite 125
  • Frederick, MD 21703
  • United States
+1 (301)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Other Healthcare Technology Systems
Corporate Office
  • 321 Ballenger Center Drive
  • Suite 125
  • Frederick, MD 21703
  • United States
+1 (301)

Monocacy Therapeutics Timeline

2026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Monocacy Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Angel (individual) 02-Oct-2026 $25K Completed Startup
3. Angel (individual) 28-Aug-2026 Completed Startup
2. Grant 02-Jul-2026 $5K Completed Startup
1. Accelerator/Incubator Completed Startup
To view Monocacy Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Monocacy Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
TEDCO Venture Capital Minority
Frederick Innovative Technology Center Accelerator/Incubator
To view Monocacy Therapeutics’s complete investors history, request access »

Monocacy Therapeutics FAQs

  • When was Monocacy Therapeutics founded?

    Monocacy Therapeutics was founded in 2025.

  • Where is Monocacy Therapeutics headquartered?

    Monocacy Therapeutics is headquartered in Frederick, MD.

  • What industry is Monocacy Therapeutics in?

    Monocacy Therapeutics’s primary industry is Drug Discovery.

  • Is Monocacy Therapeutics a private or public company?

    Monocacy Therapeutics is a Private company.

  • What is Monocacy Therapeutics’s current revenue?

    The current revenue for Monocacy Therapeutics is .

  • How much funding has Monocacy Therapeutics raised over time?

    Monocacy Therapeutics has raised $415K.

  • Who are Monocacy Therapeutics’s investors?

    TEDCO and Frederick Innovative Technology Center have invested in Monocacy Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process